# Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)

> **NCT00131053** · PHASE2 · UNKNOWN · sponsor: **Japan Adult Leukemia Study Group** · enrollment: 120 (estimated)

## Conditions studied

- Lymphoblastic Leukemia, Acute

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Prednisolone
- **DRUG:** Dexamethasone
- **DRUG:** Vincristine
- **DRUG:** Pirarubicin
- **DRUG:** Cyclophosphamide
- **DRUG:** L-asparaginase
- **DRUG:** Cytarabine
- **DRUG:** Hydrocortisone
- **DRUG:** Mercaptopurine

## Key facts

- **NCT ID:** NCT00131053
- **Lead sponsor:** Japan Adult Leukemia Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-09
- **Primary completion:** 2011-05
- **Final completion:** 2011-09
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2008-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00131053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00131053, "Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00131053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*